Antonio Antoccia Selected Research

Antonio Antoccia Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 09/2008
4	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 01/2018
3	Chromosomal Instability (Chromosome Stability) 01/2021 - 04/2003
2	Genomic Instability 05/2021 - 12/2019
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 09/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017 - 10/2012
2	Lung Neoplasms (Lung Cancer) 03/2014 - 05/2008
2	Carcinoma (Carcinomatosis) 06/2012 - 06/2012
1	Aneuploidy (Aneuploid) 01/2022
1	Brain Neoplasms (Brain Tumor) 11/2021
1	Cardiotoxicity 11/2021
1	Thalassemia 05/2021
1	alpha-Thalassemia 05/2021
1	Intellectual Disability (Idiocy) 05/2021
1	ATR-X syndrome 05/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020
1	Hyperthermia 09/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Hypersensitivity (Allergy) 12/2019
1	Glioma (Gliomas) 10/2018
1	Ovarian Neoplasms (Ovarian Cancer) 03/2016
1	Breast Neoplasms (Breast Cancer) 10/2012
1	Polyploidy 06/2012
1	Carcinogenesis 08/2009
1	Hepatoblastoma 08/2009
1	Hepatocellular Carcinoma (Hepatoma) 08/2009
1	Ataxia (Dyssynergia) 09/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2007

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 09/2008
4	LigandsIBA 11/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 05/2021 - 04/2003
2	CarbonIBA 09/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2017 - 10/2012
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2012 - 09/2008
1	activin AIBA 01/2022
1	HeterochromatinIBA 05/2021
1	alpha-GlobinsIBA 05/2021
1	DNA Transposable Elements (Element, IS)IBA 05/2021
1	X-linked Nuclear ProteinIBA 05/2021
1	DNA Polymerase I (Klenow Fragment)IBA 01/2021
1	AphidicolinIBA 01/2021
1	IonsIBA 09/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Chromobox Protein Homolog 5IBA 12/2019
1	Biological ProductsIBA 10/2018
1	naphthaleneIBA 10/2018
1	naphthalenediimideIBA 10/2018
1	tanespimycin (17AAG)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 03/2016
1	Glycoproteins (Glycoprotein)IBA 03/2016
1	MucinsIBA 03/2016
1	AntigensIBA 03/2016
1	Tumor Biomarkers (Tumor Markers)IBA 03/2016
1	Nucleotide AptamersIBA 03/2016
1	fosbretabulin (combretastatin A4)IBA 03/2014
1	ORALIT (ORS)IBA 11/2013
1	HeliumIBA 09/2013
1	Protons (Proton)IBA 09/2013
1	CalreticulinIBA 09/2012
1	CarcinogensIBA 09/2012
1	2- (4- morpholinoanilino)- 6- cyclohexylaminopurineIBA 06/2012
1	pyrazolanthroneIBA 06/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2012
1	MicroRNAs (MicroRNA)IBA 08/2009
1	Protein Kinases (Protein Kinase)IBA 09/2008
1	p38 Mitogen-Activated Protein KinasesIBA 09/2008
1	RetinoidsIBA 09/2008
1	TubulinIBA 05/2008
1	Caspase 3 (Caspase-3)IBA 01/2007
1	combretastatinIBA 01/2007
1	StilbenesIBA 01/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 09/2020
1	Radiotherapy 11/2021